Chronic fatigue syndrome is a legitimate medical condition that needs to be better understood by the medical community to help patients manage their disease and scientists to develop effective treatments.
Annual CPT code set changes affect all provider types that provide CPT professional services in all states.
Researchers are studying the effects of chronic inflammation on some of the world’s deadliest diseases and how it can be managed and prevented
The federal government, physicians and consumers all have active roles to play in reducing medication errors that so often result in adverse drug events and a high cost burden.
As the provisions of the PPACA are being put into effect, many questions and concerns remain among all sectors.
Annual vaccination against the flu can protect against cardiac-related events.
Despite evidence that vaccinating healthcare workers against influenza helps to protect patients, many still refuse — even during the worst flu season in nearly a decade.
The plasma industry continues to plan and invest for the future to assure that immunoglobulin, albumin and other life-critical plasma products are on the shelf when they’re needed.
Early referral for workup of patients with any of more than 150 occult primary immunodeficiency diseases can dramatically reduce hospitalizations, permanent disability and high costs of care.
Researchers investigated the efficacy, safety and pharmacokinetics and quality of life impact of Evogam, a new chromatographically fractionated 16% subcutaneous immunoglobulin (SCIG).
The hepatitis C virus affects 130 million to 170 million people worldwide, and the numbers are growing. But with a better understanding of the disease and advances in treatment, it no longer has to be a death sentence for most.
Billing for reimbursement of this costly, lifesaving therapy can be complicated, but for the sake of the provider and the patient, getting it right the first time can shorten approval time and prevent denials.